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Abstract
Background Considering the aging population associated with higher osteoporotic fracture risk, high prevalence of diabetes and
its effect on bone health along with lack of information on bone quality using common methods (BMD) the aim of present study
was to determine the association between trabecular bone score (TBS) and diabetes in an elderly population participating in
Bushehr Elderly Health (BEH) program.
Materials and methods This cross-sectional study was performed on data collected during the BEH Program, stage II.
Anthropometric indices were measured based on NHANES III protocol. Diabetes and pre-diabetes were defined according to
ADA Guideline 2018. Bone density was measured using DXA method (DXA, Discovery WI, Hologic Inc., USA). A software
installed on the same device (TBS iNsight® software) was applied to assess TBS values. Variables related to bone health were
compared based on their glycemic status (participants with diabetes, participants with prediabetes, and normoglycemic) using
analysis of variance. Univariate and multivariate linear and logistic regression models were used to determine the association
between TBS values and bone density in different glycemic states.
Results The data of 2263 participant aged 60 years and over were analyzed. Mean TBS values were significantly
different between participants with diabetes, participants with prediabetes, and normoglycemic groups (P = 0.004;,
however, P trend was not significant (0.400)). Mean BMD values at femoral neck and lumbar spine were significantly
higher in diabetics compared with those diagnosed with pre-diabetes; the latter also had higher bone density compared
with normoglycemic individuals (both P ANOVA test and P trends for means were < 0.01]. In univariate linear regres-
sion model, TBS values were negatively associated with pre-diabetes (β = −0.070; P < 0.001) but not with diabetes (β =
−0.002, P = 0.915). This significant relationship disappeared when the results were adjusted for BMI. In fully adjusted
multivariate logistic regression models, odds ratio linking pre-diabetes and diabetes with spinal osteoporosis was 0.861
(CI 95% 0.670–1.105) and 0.525 (CI 95% 0.392–0.701), respectively. As for femoral osteoporosis, odds ratio was 0.615
(CI 95% 0.407–0.928) and 0.968 (CI 95% 0.629–1.489), correspondingly. Moreover, for cumulative osteoporosis, the
odds were 0.843 (CI 95% 0.676–1.106) and 0.551 (CI 95% 0.415–0.732), respectively.
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Conclusion Our findings suggest that subjects with pre-diabetes and diabetes have higher bone mineral density than
normoglycemic subjects; the quality of bone, however, was not different between them. The discordance between BMD and
TBS values in participants with diabetes suggest that although these patients have higher BMD values, their quality of bone
microarchitecture may not be better than normoglycemic subjects.
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Introduction
While diabetes and osteoporosis are two seemingly unre-
lated health conditions, recent studies have demonstrated
osteoporotic fractures to be more prevalent among diabet-
ic individuals [1–4].
Several studies have linked type 2 diabetes with higher
bone mineral density (BMD) values in both men and
women [5, 6]. This is while increased risk of fractures is
seen in patients with type one and two diabetes, despite
the reported high BMD values [1, 3, 7]. Conversely,
others have indicated a significant decrease in femoral
BMD values along with an increased risk of hip fracture
in men suffering from diabetes mellitus [8]. This is while
some studies have not failed to show any increment in
fracture risk in this group [9]. These contradictory results
confirm the shortcoming of BMD in predicting the risk of
osteoporotic fractures, mainly due to the fact that it is not
a good indicator of bone quality.
Trabecular bone score (TBS), on the other hand, is a mea-
sure of bone texture correlated with bone microarchitecture.
Low TBS values are considered a marker of impaired bone
quality and thus is linked with increasing prevalence and in-
cidence of osteoporotic fractures [10]. A few studies have
assessed the association between high blood glucose levels
at pre-diabetes status with osteoporosis and low TBS values.
This study aimed to evaluate the association between dia-
betes and pre-diabetes and quantity and quality of bone
microarchitecture evaluated by BMD and TBS, respectively,
in a group of community dwelling older adults.
Materials and methods
Study population
The protocols of phase one and two of the Bushehr
Elderly Health (BEH) program is described elsewhere
[11, 12] . In summary, the BEH program is a prospective
population-based longitudinal study with multistage
stratified-cluster sampling aimed at determining the prev-
alence of non-communicable diseases (NCD)-related risk
factors among a representative urban sample of older pop-
ulation in Bushehr, the capital city of a province located
in South Iran.
Data collection
Demographic data were collected through interviews with the
participants. Lifestyle information such as physical activity and
smoking were collected using Global Physical Activity
Questionnaire (QPAG) and a brief Tobacco Questionnaire.
Anthropometric measures including height, weight, and waist
circumferenceweremeasured based on theNHANES III anthro-
pometric measurement protocol [13]. Height and weight were
measured to the nearest 0.1 cm, and 0.1 kg, correspondingly.
Body mass index (BMI) was calculated by dividing weight
(kg) by squared height (m2). For laboratory measurements, sam-
ples were collected after 12 h overnight fasting. Fasting plasma
glucose (FPG) FPG was measured by an auto-analyzer using
Enzymatic (CHE & CHO) colorimetric method. Hemoglobin
A1C (HbA1C) was measured using Boranate affinity methods.
Total body composition also BMDvalues at lumbar spine and
total hip were measured using dual x-ray absorptiometry (DXA,
Discovery WI, Hologic Inc., USA). TBS of L1-L4 was assessed
using TBS iNsight® software installed on our DXA machine.
Definitions
Pre-diabetes and diabetes (DM) In this study, we used the
2018 American Diabetes Association (ADA) definition for
– Pre-diabetes: FBG ≥100 and < 126 or hemoglobin
A1C ≥ 5.7% and < 6.5% in individuals with no history
of diabetes, and
– Diabetes: FPG ≥ 126 mg/dl or HbA1C ≥ 6.5%, or
pharmacological treatment in patients with a positive
history of diabetes [14].
Osteoporosis Femoral neck and lumbar spine osteoporosis
were defined when calculated T-scores were equal or less than
−2.5. Cumulative osteoporosis was defined in the presence of
osteoporosis in the two mentioned sites.
Statistical analysis
Normal distribution of continuous variables was assessed using
Kolmogorov-Smirnov test. Mean and standard deviation was
used to express descriptive statistics. Statistical significance
was defined as a P value less than 0.05. Uni- and multivariable
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linear and logistic regression models were used to assess the
association between different definitions of osteoporosis (based
on BMD and TBS values) and glycemic status (pre-diabetes and
diabetes). Any independent variables with a P value ≤0.20 in
univariate model analysis along with those with a significant
relationship with osteoporosis in literature were considered in
the final multivariate model (in final multivariable linear and
logistic regression models, adjustment was performed for age,
sex, physical activity, current smoking, and BMI). All analyses
were performed using STATA (Release 12, Statistical software.
College Station, Texas: STATA Corp LP).
Ethical consideration
All the participants signed a written informed consent
before taking part in the study that was approved by the
Research Ethics Committee of Bushehr University of
Medical Sciences and Ethical Board Committee of the
Endocrinology & Metabolism Research Institute (Ethical
Code: IR.TUMS.EMRI.REC.1394.0036).
Results
The mean age of the participants was 69.27 (SD: 6.32) years
and 51.79% of them were female. General characteristics of
the participants according to their glycemic status are illustrat-
ed in Table 1.
As it could be seen in Table 2, mean BMD value at both
L1-L4 and neck of femur was significantly higher in partici-
pants with diabetes (Figs. 1 and 2). This is while such as a
correlation was not reported between mean TBS and glycemic
status (P trend = 0.400) (Fig. 3).
Univariate linear regression results revealed pre-diabetes
status had a significant but negative association with TBS
values (β = −0.070, P = 0.001); no such an association was
reported between diabetes status and TBS values (β =
−0.002, P = 0.915). Diabetes status, however, was significant-
ly associated with BMD values at neck of femur and spine
(β = 0.083, and β = 0.125, respectively; Ps <0.05) (Table 3).
Moreover, there was a significant association between BMD
at L1-L4 and HbA1c values in multivariable regression model
even after adjusting for diabetes status (β standardized =
0.051 and P = 0.025). This association is stronger for BMD
at neck of femur after full adjustment (after adjustment for age,
gender, physical activity, smoking, and BMI) (β standard-
ized = 0.075 and P = 0.001). However, there was no such an
association between TBS and HbA1c values (β standard-
ized = 0.031, P = 0.197).
Univariate logistic regression analysis revealed a reverse
association between glycemic status and osteoporosis
(Table 4). On the other word, in multivariable models, the risk
Table 1 General characteristics of the participants based on their glycemic status
Total subjects
N = 2263
Subjects with diabetes
N = 459
Subjects with pre-diabetes
N = 620
Normoglycemic subjects
N = 1184
P value
Age year mean(SD) 69.27 (6.32) 68.22 (6.31) 69.55 (6.53) 69.55 (6.55) <0.001
Gender (female) No (%) 1172 (51.79) 245 (53.38) 346 (55.81) 581 (49.07) 0.019
BMI Kg/m2 mean (SD) 27.52 (4.96) 27.96 (4.76) 28.81 (5.32) 26.67 (4.66) <0.001
WC cm mean (SD) 98.73 (12.10) 100.85 (10.99) 101.48 (12.21) 96.48 (12.02) <0.001
Physical Inactivity No (%) 75.25 (1703) 358 (78.00) 473 (76.29) 73.65 (872) 0.008
Cigarette Smoking No (%) 396 (17.50) 71 (15.50) 80 (12.90) 245 (20.69) 0.007
BMI, Body Mass Index; WC, Waist Circumference
Table 2 Bone health status of the individuals based on their glycemic status
Total subjects
N = 2263
Participants with diabetes
N = 459
Participants with
prediabetes
N = 620
Normoglycemic
subjects
N = 1184
P value P trend
Neck of femur BMD mean (SD) gr/cm2 0.657 (0.142) 0.677 (0.150) 0.661 (0.146) 0.648 (0.136) <0.001* 0.001
Lumbar BMD mean (SD) gr/cm2 0.899 (0.182) 0.936 (0.180) 0.910 (0.180) 0.879 (0.182) <0.001* <0.001
TBS (L1-L4) mean (SD) 1.296 (0.106) 1.300 (0.109) 1.284 (0.110) 1.301 (0.103) 0.004* 0.400
Neck of femur osteoporosis No (%) 230 (10.16) 39 (8.50) 51 (8.23) 140 (11.82) 0.022** 0.029
Spinal osteoporosis No (%) 653 (28.86) 93 (20.26) 168 (27.10) 392 (33.11) <0.001** <0.001
Cumulative osteoporosis No (%) 700 (30.93) 104 (22.66) 180 (29.03) 416 (35.14) <0.001** <0.001
*P value of ANOVA
**P value of Chi2
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of femoral osteoporosis was about 38% less in participants
with prediabetes in compare to normoglycemic individuals.
Furthermore, in participants with diabetes and participants
with prediabetes the risk for spinal osteoporosis is near to half
and third fourth in compare to normal glycemic subjects,
respectively. In the fully adjusted model (after adjustment
for age, gender, physical activity, smoking, and BMI) a
significant association was reported between diabetes and
spinal osteoporosis (odds ratio = 0.524; P < 0.001) as well
as pre-diabetes and femoral osteoporosis (odds ration =
0.615; P = 0.021). The association between pre-diabetes
and spinal osteoporosis or that of diabetes and femoral
osteoporosis was significant (Table 4).
Discussion
In this community-based study, the relationship between os-
teoporosis and glycemic status was assessed in an Iranian
population. The prevalence of spinal and cumulative osteopo-
rosis was significantly lower in participants with diabetes.
Moreover, osteoporosis at both of the studied sites was more
prevalent in normoglycemic subjects than the participants
with prediabetes. Whiles, the frequency of femoral osteopo-
rosis were less common in participants with diabetes also in
participants with prediabetes. Furthermore, bone mineral den-
sity at both spinal and neck of femur sites were higher in
people with diabetics than group with prediabetes. In addition,
the BMD at these two sites in subjects with pre-diabetes were
higher than normal glycemic individuals.
On the contrary, mean lumbar TBS values did not differ
among patients suffering from diabetes and non-diabetic individ-
uals. This is while TBS values were significantly lower among
participants with prediabetes compared with normoglycemic
subjects. The association between TBS value and glycemic sta-
tus became statistically non-significant after adjusting for BMI.
Higher BMI values in subjects with pre-diabetes can explain
lower values of TBS in this population, suggesting that glycemic
condition has no effect on TBS spontaneously. Compared with
normoglycemic individuals, spinal and cumulative osteoporosis
were about 45% less common among participants with diabetes;
neck of femur osteoporosis, conversely, was less significantly
common in people with pre-diabetes.
The relation between diabetes and BMD values is controver-
sial, with inconsistent results regarding the influence of increased
serum glucose levels on bone health [8, 15–17]. Von et al. re-
ported an inverse association between serum glucose levels and
bone health in men; the association was positive in women [18].
Rotterdam study revealed that serum glucose levels were posi-
tively associated with BMD values at femoral neck in both gen-
ders independent of their glycemic status. Our study showed
higher BMDs in diabetics that is in consistent with the results
of the Rotterdam [19] and NHANS III studies [16].
Irrespective of BMD values, risk of fracture is reported to be
higher in diabetics compared with non-diabetics [20]. As a re-
sult, the use of TBS is suggested to improve the diagnostic value
of lumbar spine DXA in diabetic patients. While BMD is typi-
cally normal or higher in diabetic patients, TBS appears to be
lower in diabetics compared with non-diabetic subjects [21].Fig. 2 Mean BMD values at lumbar spines based on glycemic status
Fig. 1 Mean BMD values at neck of femur based on glycemic status Fig. 3 Mean TBS values based on glycemic status
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Leslie et al. showed that lumbar spine TBS can predict osteopo-
rotic fractures irrespective of the glycemic status [21]. In addi-
tion, TBS is shown to be positively associated with good glyce-
mic control [22, 23]. In our study, the significant relationship
between diabetes and TBS disappeared after adjustment for
BMI. Similar results were observed in a cohort study conducted
in Germany. In this study, no significant difference was noted in
TBS values between diabetics and non-diabetics. However,
TBS and HbA1c values were independently associated with
fracture risk, with TBS values lower than 1.42 predictive for
fracture [24]. Nevertheless, the Manitoba cohort study on
29,407 postmenopausal women over 50 in Canada and the
Ansung cohort on 1229 men and 1529 postmenopausal women
over 50 in Korea, lumbar TBS was lower in diabetic patients.
Similar to the present study, these two studies revealed higher
mean BMD values in diabetic patients compared with non-
diabetics [21, 23]. TBS was also inversely associated with
HbA1c, FBS, fasting insulin and HOMA-IR1 [23]. While these
results are of major clinical interest, it should be noted that TBS
illustrates an indirect picture of bone microarchitecture with low
resolution and reduced image quality.
The reason behind increased risk of fracture in diabetic
patients is multifactorial and includes changes in bone com-
ponent and structural abnormalities [25]. High levels of serum
glucose in diabetic patients causes the accumulation of ad-
vanced glycosylation end-products in the bonematrix, leading
to the formation of a more brittle bone [26–28]. Increased
cortex porosity reported in women suffering from diabetes
mellitus [29] could result in decreased bone strength, which
is not detectable by DXA [30]. Furthermore, there are several
evidences reporting potential defect in the trabecular bone
microstructure in patients suffering from type 1 and 2 dia-
betics [31, 32]. This could explain low-impact fractures.
High insulin levels are another mechanism explaining
higher fracture rates in diabetic patients, regardless of their
higher BMD values. Insulin is an anabolic hormone that stim-
ulates bone formation. It increases osteoblast proliferation,
promoting collagen synthesis. Insulin growth factor-1 (IGF-
1) affects bone in similar ways. Studies have reported a pos-
itive correlation between IGF-1 and BMD values, and a neg-
ative association between IGF-1 and fracture [33, 34].
On the other hand, obesity is a potential confounder in the
relationship between diabetes and bone health. Recently, obesity
has also been reported as a risk factor for fracture [35–37].
Trabecular and cortical microarchitectural abnormalities have
been reported in obese participants; their diabetic status, howev-
er, was not studied [38]. Moreover, lower bone formation, ele-
vated serum sclerostin, increased adipocyte markers, and abnor-
mal bone marrow fat composition have been reported in obese
individuals [39, 40]. It is likely that the effect of diabetes on bone1 Homeostatic model assessment- Insulin resistance
Table 4 Association between osteoporosis and diabetes and pre-diabetes in female participants
Spinal Osteoporosis Neck of Femur Osteoporosis Cumulative Osteoporosis
Odds ratio 95% CI odds ratio P value Odds ratio 95% CI odds ratio P value Odds ratio 95% CI
odds ratio
P value
Univaraiable Model
Normoglycemic Reference Reference Reference
Participants with prediabetes 0.751 0.606–0.931 <0.001 0.667 0.477–0.934 0.018 0.755 0.612–0.932 0.009
Participants with diabetes 0.513 0.397–0.664 <0.001 0.691 0.476–1.003 0.052 0.541 0.422–0.694 <0.001
First Multivariable Model**
Normoglycemic Reference Reference Reference
Participants with prediabetes 0.651 0.517–0.818 <0.001 0.511 0.349–0.748 0.001 0.644 0.513–0.809 <0.001
Participants with diabetes 0.487 0.371–0.639 <0.001 0.812 0.540–1.223 0.319 0.511 0.392–0.666 <0.001
Second Multivariable Model***
Normoglycemic Reference Reference Reference
Participants with prediabetes 0.699 0.550–0.888 0.003 0.538 0.360–0.804 0.003 0.690 0.544–0.875 0.002
Participants with diabetes 0.494 0.372–0.856 <0.001 0.898 0.586–1.376 0.621 0.521 0.395–0.687 <0.001
Final Multivariable Model****
Normoglycemic Reference Reference Reference
Participants with prediabetes 0.861 0.670–1.105 0.240 0.615 0.407–0.928 0.021 0.843 0.676–1.106 0.176
Participants with diabetes 0.524 0.392–0.701 <0.001 0.968 0.629–1.489 0.881 0.551 0.415–0.732 <0.001
**Adjusted for age and gender
***Adjusted for age, gender, current smoking, and physical activity
****Adjusted for age, gender, current smoking, physical activity, and BMI
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health, due to known and unknown factors such as body bio-
chemical balance and lifestyle, is stronger in certain ages. Also,
medications used by diabetics may affect the results differently.
This paper has several strengths, as it was based on a
population-based study conducted on the elderly population
with specific attention paid to bone health. Moreover, bone
indicators such as BMD and TBS were evaluated together.
This study, however, suffered from several limitations.
BMD and TBS were assessed only in certain bone areas; this
is while the relationship between diabetes with BMD and TBS
may differ in various regions. Moreover, considering the
cross-sectional nature of this study, it is not possible to deter-
mine the causal relationship between diabetes and BMD
values. A longitudinal study would be more suitable for this
purpose. In this study, participants with diabetes were ana-
lyzed regardless of the diabetes type. However, different eti-
ologies of type 1 and type 2 diabetes along with their varied
therapeutic intervention could affect the outcome.
Conclusion
Our findings suggest that osteoporosis as measured by
BMD at lumbar and femoral site is less common among
participants with diabetess compared with participants
without diabetes. It seems that diabetes, regardless of back-
ground factors such as BMI, is associated with increased of
bone density. This is while an individual’s glycemic con-
dition does not influence bone quality and thus bone
health. This was confirmed by TBS. Longitudinal studies
are needed to determine the effect of pre-diabetes and dia-
betes on bone density. More information is needed regard-
ing the pathogenesis of high blood glucose levels on bone
health and the higher risk of fracture in diabetic patients.
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
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